Lubricating Block Copolymers Mimicking Lubricin for Boundary Lubrication
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoarthritis, such as non-steroidal anti-inflammatories and hyaluronic acid injections, fail to effectively reduce the coefficient of friction in joint lubrication, and large-scale production of natural lubricants like lubricin is challenging due to protein complexity and high glycosylation, necessitating a more effective lubricating agent for joint and bone surfaces.
Innovation Solution
Development of block copolymers mimicking the structure of lubricin, comprising a mucin-like domain for lubrication and a cartilage-binding domain, synthesized through reversible addition-fragmentation chain-transfer polymerization, to reduce friction in boundary lubrication conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural lubricants like lubricin are used for boundary lubrication, then lubrication effectiveness is improved, but manufacturing complexity and cost increase due to protein complexity and high glycosylation
Solution Approach 1:
The patent creates simplified polymer copies of lubricin's key functional domains (mucin-like domain for lubrication and C-terminal domain for binding) using synthetic polymers that mimic the essential properties without requiring complex protein synthesis and glycosylation processes
Solution Approach 2:
The invention uses block copolymer compositions combining hydrophilic blocks (mimicking mucin domain) and anchoring blocks (mimicking C-terminal domain) to create a composite material that reproduces lubricin's dual functionality of lubrication and surface binding
2Duration of action of stationary object
If hyaluronic acid is used for lubrication, then synovial fluid viscosity is improved, but coefficient of friction reduction is insufficient under boundary lubrication conditions
Solution Approach 1:
The patent applies different functional blocks to different regions of the copolymer molecule: hydrophilic blocks provide lubrication at the interface while anchoring blocks provide binding to cartilage surface, creating local functional specialization that addresses both viscosity and friction reduction
Solution Approach 2:
The block copolymers act as intermediaries between synovial fluid and cartilage surface, providing both viscous properties in the fluid phase and binding capability to the surface, bridging the gap between hyaluronic acid's fluid properties and lubricin's surface properties
3Reliability
If lubricin is used for cartilage lubrication, then boundary mode friction is reduced, but production scalability is limited due to large-scale manufacturing challenges
Solution Approach 1:
The patent replaces complex natural lubricin protein with simplified synthetic polymer copies that can be manufactured at scale using standard polymer synthesis techniques, eliminating the need for complex biomanufacturing processes
Solution Approach 2:
The invention changes the fundamental chemical parameters from protein-based to polymer-based, allowing production through well-established polymer chemistry methods that are more scalable and cost-effective than recombinant protein production
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The block copolymers significantly reduce the coefficient of friction on both cartilage and bone surfaces, achieving lubrication comparable to natural lubricin, thereby potentially slowing osteoarthritis progression and providing relief from bone-on-bone contact.
Implementation Method 1
Lubricin reduces the coefficient of friction (COF) of articular cartilage in the boundary mode by as much as 70 percent
Data Source
AI summary
The invention relates to methods of lubricating biological tissue, such as joints, bone, ocular tissue, nasal tissue, tendons, tendon capsule, and vaginal tissue, by contacting the biological tissue with an effective amount of a block copolymer lubricating composition which functions at least or better than lubricin. In particular embodiments, the method is used to treat osteoarthritis. In specific embodiments, the block copolymer has an ammonium-containing polymer block and a non-ionic hydrophilic polymer block, or the copolymer has a carboxylic acid-containing polymer block and a non-acid non-ionic hydrophilic polymer block.


